| | | | 28272773 | Published |
| Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice.Zhang H, Nair V, Saha J, Atkins KB, Hodgin JB, Saunders TL, Myers MG, Werner T, Kretzler M, Brosius FC Kidney international, 2017 | | | 28554737 | Published |
| | | | 27333885 | Published |
| Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.Pedigo CE, Ducasa GM, Leclercq F, Sloan A, Mitrofanova A, Hashmi T, Molina-David J, Ge M, Lassenius MI, Forsblom C, Lehto M, Groop PH, Kretzler M, Eddy S, Martini S, Reich H, Wahl P, Ghiggeri G, Faul C, Burke GW, Kretz O, Huber TB, Mendez AJ, Merscher S, Fornoni A The Journal of clinical investigation, 2016 (126), 3336 - 50 | | | 27482889 | Published |
| Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications.Sas KM, Kayampilly P, Byun J, Nair V, Hinder LM, Hur J, Zhang H, Lin C, Qi NR, Michailidis G, Groop PH, Nelson RG, Darshi M, Sharma K, Schelling JR, Sedor JR, Pop-Busui R, Weinberg JM, Soleimanpour SA, Abcouwer SF, Gardner TW, Burant CF, Feldman EL, Kretzler M, Brosius FC, Pennathur S JCI insight, 2016 (1), e86976 | | | 27699244 | Published |
| Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.Yoo TH, Pedigo CE, Guzman J, Correa-Medina M, Wei C, Villarreal R, Mitrofanova A, Leclercq F, Faul C, Li J, Kretzler M, Nelson RG, Lehto M, Forsblom C, Groop PH, Reiser J, Burke GW, Fornoni A, Merscher S Journal of the American Society of Nephrology : JASN, 2015 (26), 133 - 47 | | | 24925721 | Published |
| MicroRNA-21 in Glomerular Injury.Lai JY, Luo J, O'Connor C, Jing X, Nair V, Ju W, Randolph A, Ben-Dov IZ, Matar RN, Briskin D, Zavadil J, Nelson RG, Tuschl T, Brosius FC, Kretzler M, Bitzer M Journal of the American Society of Nephrology : JASN, 2014 | | | 25145934 | Published |
| Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.Hodgin JB, Nair V, Zhang H, Randolph A, Harris RC, Nelson RG, Weil EJ, Cavalcoli JD, Patel JM, Brosius FC, Kretzler M Diabetes, 2013 (62), 299 - 308 | | | 23139354 | Published |
| From Single Nucleotide Polymorphism to Transcriptional Mechanism: A Model for FRMD3 in Diabetic Nephropathy.Martini S, Nair V, Patel SR, Eichinger F, Nelson RG, Weil EJ, Pezzolesi MG, Krolewski AS, Randolph A, Keller BJ, Werner T, Kretzler M Diabetes, 2013 (62), 2605 - 2612 | | | 23434934 | Published |
| Transcriptome analysis of proximal tubular cells (HK-2) exposed to urines of type 1 diabetes patients at risk of early progressive renal function decline.Wanic K, Krolewski B, Ju W, Placha G, Niewczas MA, Walker W, Warram JH, Kretzler M, Krolewski AS PLoS ONE, 2013 (8), e57751 | | Submitted Externally | 23505438 | Published |
| Diabetic Nephropathy: A National Dialogue.Breyer MD, Coffman TM, Flessner MF, Fried LF, Harris RC, Ketchum CJ, Kretzler M, Nelson RG, Sedor JR, Susztak K, on behalf of the Kidney Research National Dialogue (KRND) Clinical journal of the American Society of Nephrology : CJASN, 2013 | | | 23788618 | Published |
| Cyclodextrin protects podocytes in diabetic kidney disease.Merscher-Gomez S, Guzman J, Pedigo CE, Lehto M, Aguillon-Prada R, Mendez A, Lassenius MI, Forsblom C, Yoo T, Villarreal R, Maiguel D, Johnson K, Goldberg R, Nair V, Randolph A, Kretzler M, Nelson RG, Burke GW, Groop PH, Fornoni A Diabetes, 2013 (62), 3817 - 3827 | | | 23835338 | Published |
| Targeted Glomerular Angiopoietin-1 Therapy for Early Diabetic Kidney Disease.Dessapt-Baradez C, Woolf AS, White KE, Pan J, Huang JL, Hayward AA, Price KL, Kolatsi-Joannou M, Locatelli M, Diennet M, Webster Z, Smillie SJ, Nair V, Kretzler M, Cohen CD, Long DA, Gnudi L Journal of the American Society of Nephrology : JASN, 2013 (25), 33 - 42 | | Submitted Externally | 24009238 | Published |
| Bcl-2-modifying factor induces renal proximal tubular cell apoptosis in diabetic mice.Lau GJ, Godin N, Maachi H, Lo CS, Wu SJ, Zhu JX, Brezniceanu ML, Chénier I, Fragasso-Marquis J, Lattouf JB, Ethier J, Filep JG, Ingelfinger JR, Nair V, Kretzler M, Cohen CD, Zhang SL, Chan JS Diabetes, 2012 (61), 474 - 484 | | | 22210314 | Published |
| | | | 22733404 | Published |
| Role of mTOR in podocyte function and diabetic nephropathy in humans and mice.Gödel M, Hartleben B, Herbach N, Liu S, Zschiedrich S, Lu S, Debreczeni-Mór A, Lindenmeyer MT, Rastaldi MP, Hartleben G, Wiech T, Fornoni A, Nelson RG, Kretzler M, Wanke R, Pavenstädt H, Kerjaschki D, Cohen CD, Hall MN, Rüegg MA, Inoki K, Walz G, Huber TB The Journal of clinical investigation, 2011 (121), 2197 - 2209 | | | 21606591 | Published |
| mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice.Inoki K, Mori H, Wang J, Suzuki T, Hong S, Yoshida S, Blattner SM, Ikenoue T, Rüegg MA, Hall MN, Kwiatkowski DJ, Rastaldi MP, Huber TB, Kretzler M, Holzman LB, Wiggins RC, Guan KL The Journal of clinical investigation, 2011 (121), 2181 - 2196 | | | 21606597 | Published |
| | | | 21858169 | Published |
| | | | 21926103 | Published |
| The management of diabetic neuropathy in CKD.Pop-Busui R, Roberts L, Pennathur S, Kretzler M, Brosius FC, Feldman EL American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010 (55), 365 - 385 | | | 20042258 | Published |
| Renal gene and protein expression signatures for prediction of kidney disease progression.Ju W, Eichinger F, Bitzer M, Oh J, McWeeney S, Berthier CC, Shedden K, Cohen CD, Henger A, Krick S, Kopp JB, Stoeckert CJ, Dikman S, Schröppel B, Thomas DB, Schlondorff D, Kretzler M, Bottinger EP The American journal of pathology, 2009 (174(6)), 2073 - 2085 | | | 19465643 | Published |
| Mouse Models of Diabetic Nephropathy: A Midstream Analysis from the Diabetic Complications ConsortiumFrank C. Brosius IIIa, Charles E. Alpersb, Erwin P. Bottingerc, Matthew D. Breyerd, ThomasM. Coffmane, Susan B. Gurleye, Raymond C. Harrisf, Masao Kakokig, Matthias Kretzler, Edward H. Leiterh, Moshe Levii, Richard A. McIndoej, Kumar Sharmak, Oliver Smithiesg, Katalin Susztakl, Nobuyuki Takahashig, Takamune Takahashif Journal of the American Society of Nephrology : JASN, 2009 (20(12)), 2503 - 2512 | | | 19729434 | Published |
| | | | 18511444 | Published |
| | | | 18583417 | Published |
| Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathyHongyu Zhang, Jharna Saha, MaryLee Schin, Jaeman Byun, Matthias Kretzler, Eva L. Feldman, David A. Weild, Subramaniam Pennathur, Frank C. Brosius III American journal of physiology. Renal physiology, 2008 (295(4)), F1071 - F1081 | | | 18667486 | Published |
| Improved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysis.Cohen CD, Lindenmeyer MT, Eichinger F, Hahn A, Seifert M, Moll AG, Schmid H, Kiss E, Gröne E, Gröne HJ, Kretzler M, Werner T, Nelson PJ PLoS ONE, 2008 (3), e2937 | | Submitted Externally | 18698414 | Published |
| | | | 18704688 | Published |
| Enhanced Expression of JAK-STAT Pathway Members in Human Diabetic NephropathyCeline C. Berthier, PhD., Hongyu Zhang, M.D., MaryLee Schin, B.S., Anna Henger, PhD, Robert G. Nelson, M.D., PhD, Berne Yee, M.D., Anissa Boucherot, PhD., Christin Carter-Su, PhD., Lawrence S. Argetsinger, PhD., Maria Pia Rastaldi, M.D., Frank C. Brosius, M.D., Matthias Kretzler, M.D Diabetes, 2008 (Epub), 469 - 477 | | | 19017763 | Published |